Toggle navigation
News
OK
NewsOK
News
Weather
Opinion
Business
Sports
Life
Photos
Videos
Brandinsight
Shopping
Classifieds
Homes
Jobs
Cars
Legals
Shop
Account
Settings
Subscribe
Contact Us
Support
Privacy Policy
Terms of Use
About our ads
Advertise with us
The Oklahoman
Market Watch
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Gw Pharma ADR
(NQ:
GWPH
)
141.70
USD
+3.28 (+2.37%)
Official Closing Price
Updated: 7:55 PM EST, Jan 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Gw Pharma ADR
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
NXP Semiconductors NV (NASDAQ:NXPI) and GW Pharmaceuticals Plc (NASDAQ:GWPH) Added to Growing Stock Report's NASDAQ Gainers Watch List.
February 07, 2014
New York, NY -- (SBWIRE) -- 02/07/2014 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding NXP Semiconductors NV (NASDAQ:NXPI) and GW Pharmaceuticals plc (NASDAQ:GWPH).
From
SBWire - Latest Press Releases
Medical Marijuana Industry Continues Rapid Expansion As Leaders Acquire New Dispensary Sites
February 05, 2014
From
PR Newswire
GW Pharmaceuticals plc Reports First Quarter 2014 Financial Results and Operational Progress
February 04, 2014
From
GlobeNewswire News Releases
GW Pharmaceuticals to Report Q1 2014 Financial Results and Host Conference Call on 5 February, 2014
January 28, 2014
From
GlobeNewswire News Releases
Search for Morning Buzz (OTCMKTS:ACUS, NASDAQ:BDSI, NASDAQ:ACRX, NASDAQ:GWPH)
January 23, 2014
New York, NY -- (SBWIRE) -- 01/23/2014 -- Acusphere, Inc. (OTCMKTS:ACUS) is -0.021 - -2.51% from the previous close of $0.835. It traded between $0.8111 - 1.11 with total traded volume of 19282 shares....
From
SBWire - Latest Press Releases
Mentor Capital Cannabis Index Up 325% in First Three Weeks of 2014
January 22, 2014
From
Business Wire News Releases
GW Pharmaceuticals plc Announces the Closing of Its U.S. Follow-on Offering of American Depositary Shares (ADSs) on the NASDAQ Global Market and Full Exercise of Underwriters' Option to Purchase Addit
January 14, 2014
Offering Raises $101.1 Million
From
GlobeNewswire News Releases
Healthcare Companies Report Petition Submission, Pricing of Follow-On Offerings and Stock Price Movements - Research Report on Johnson & Johnson, GW Pharma, Conatus Pharma, Chelsea, and Insmed
January 14, 2014
From
PR Newswire
Ipsen and GW Pharmaceuticals plc Enter Into Agreement for Ipsen to Promote and Distribute Sativex(R) in Latin America
January 13, 2014
From
GlobeNewswire News Releases
Ipsen and GW Pharmaceuticals plc Enter into Agreement for Ipsen to Promote and Distribute Sativex® in Latin America
January 13, 2014
From
Business Wire News Releases
Inclusive Analysis Of: MagneGas Corporation (NASDAQ:MNGA), Sangamo Biosciences, Inc. (NASDAQ:SGMO), Prospect Global Resources Inc (NASDAQ:PGRX), GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH)
January 10, 2014
New York City, NY -- (SBWIRE) -- 01/10/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to...
From
SBWire - Latest Press Releases
Stocks on the Run - GW Pharmaceuticals PLC- ADR(NASDAQ:GWPH), Monster Worldwide, Inc.(NYSE:MWW), New Residential Investment Corp(NYSE:NRZ), Matador Resources Co(NYSE:MTDR)
January 10, 2014
Las Vegas, NV -- (SBWIRE) -- 01/10/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more...
From
SBWire - Latest Press Releases
Small Cap Stocks with Escalations - Sangamo Biosciences, Inc. (NASDAQ:SGMO), GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), eHealth, Inc. (NASDAQ:EHTH), XOMA Corp (NASDAQ:XOMA)
January 10, 2014
Stamford, CT -- (SBWIRE) -- 01/10/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock...
From
SBWire - Latest Press Releases
NASDAQ Active Stock Watch List: SolarCity Corporation (NASDAQ:SCTY) and GW Pharmaceuticals plc (NASDAQ:GWPH) Added to Growing Stock Report's NASDAQ Active Stock Watch List.
January 09, 2014
New York, NY -- (SBWIRE) -- 01/09/2014 -- Growing Stock Report expands its NASDAQ Active Stock Watch List adding SolarCity Corporation (NASDAQ:SCTY) and GW Pharmaceuticals plc (NASDAQ:GWPH).
From
SBWire - Latest Press Releases
GW Pharmaceuticals plc Announces Pricing of U.S. Follow-On Offering of ADSs Raising $87.9 Million on NASDAQ Global Market
January 08, 2014
From
PR Newswire
GW Pharmaceuticals Files Registration Statement for Proposed Follow-On Offering
December 20, 2013
From
PR Newswire
GW Pharmaceuticals plc Announces U.S. Patent Allowance for Use of Cannabinoids in Treating Glioma
December 10, 2013
From
PR Newswire
Edison highlights the potential of GW Pharmaceuticals' cannabinoid pipeline and furthers its US healthcare presence
December 10, 2013
From
PR Newswire
Events, Marketing Recommendation, FDA Meeting, and Marketing Authorization - Research Report on Hospira, Novo Nordisk, Repros Therapeutics, GW Pharmaceuticals, and Envision Healthcare
December 02, 2013
Editor Note: For more information about this release, please scroll to bottom
From
PR Newswire
GW Pharmaceuticals to Present at the Piper Jaffray 25th Annual Health Care Conference
December 01, 2013
From
PR Newswire
GW Pharmaceuticals plc Announces Sativex® Regulatory Approval in Switzerland
November 26, 2013
-Sativex® Now Approved in 23 Countries-
From
PR Newswire
GW Pharmaceuticals plc Reports 2013 Q4 and Full Year Financial Results
November 18, 2013
- Conference Call Today at 8:00 a.m. ET, 1:00 p.m. GMT -
From
PR Newswire
GW Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference
November 18, 2013
From
PR Newswire
GW Pharmaceuticals Provides Update on Orphan Program in Childhood Epilepsy for Epidiolex®
November 14, 2013
- Orphan Drug Designation Granted for Epidiolex in Dravet syndrome by the FDA -
From
PR Newswire
GW Pharmaceuticals to Report 2013 Q4 and Full Year Financial Results and Host Conference Call on 19 November, 2013
November 11, 2013
From
PR Newswire
GW Pharmaceuticals Commences Phase 1b/2a Clinical Trial for the Treatment of Glioblastoma Multiforme (GBM)
November 10, 2013
-Study Features THC and CBD as the Primary Cannabinoids-
From
PR Newswire
GW Pharmaceuticals Announces Successful Closing of Mutual Recognition Procedure for Sativex® in France
October 20, 2013
From
PR Newswire
Global Distribution Agreements, New Clinical Study Results, FDA Announcements, and Earnings Schedules - Research Report on Life Technologies, GW, Novartis, Salix, and Mallinckrodt
October 10, 2013
Editor Note: For more information about this release, please scroll to bottom
From
PR Newswire
Exclusive Video Interviews With CEOs Now on Equities.com: CGIX, CYTR, GWPH, HTBX, OPXA
October 09, 2013
From
GlobeNewswire News Releases
Eye-Catching Stocks: GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), C.H. Robinson Worldwide, Inc, Yandex NV (NASDAQ:YNDX), Liberty Interactive
October 08, 2013
Middletown, DE -- (SBWIRE) -- 10/08/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny...
From
SBWire - Latest Press Releases
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.